These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
898 related items for PubMed ID: 19383179
1. The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block. Fesslova V, Vignati G, Brucato A, De Sanctis M, Butera G, Pisoni MP, Chiappa E, Acaia B, Meroni PL. Cardiol Young; 2009 Jun; 19(3):282-90. PubMed ID: 19383179 [Abstract] [Full Text] [Related]
2. Isolated congenital atrioventricular block diagnosed in utero: natural history and outcome. Breur JM, Kapusta L, Stoutenbeek P, Visser GH, van den Berg P, Meijboom EJ. J Matern Fetal Neonatal Med; 2008 Jul; 21(7):469-76. PubMed ID: 18570127 [Abstract] [Full Text] [Related]
3. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK. Circulation; 2004 Sep 21; 110(12):1542-8. PubMed ID: 15353508 [Abstract] [Full Text] [Related]
4. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Saleeb S, Copel J, Friedman D, Buyon JP. Arthritis Rheum; 1999 Nov 21; 42(11):2335-45. PubMed ID: 10555029 [Abstract] [Full Text] [Related]
5. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block. Mevorach D, Elchalal U, Rein AJ. Curr Opin Rheumatol; 2009 Sep 21; 21(5):478-82. PubMed ID: 19584727 [Abstract] [Full Text] [Related]
6. [Intrauterine therapy and outcome in four pregnancies of one mother with anti ro-autoantibody positive Sjoegren's syndrome]. Zemlin M, Bauer K, Dörner T, Altinöz H, Versmold H. Z Geburtshilfe Neonatol; 2002 Sep 21; 206(1):22-5. PubMed ID: 11887252 [Abstract] [Full Text] [Related]
7. Direct fetal therapy for hydrops secondary to congenital atrioventricular heart block. Anandakumar C, Biswas A, Chew SS, Chia D, Wong YC, Ratnam SS. Obstet Gynecol; 1996 May 21; 87(5 Pt 2):835-7. PubMed ID: 8677107 [Abstract] [Full Text] [Related]
8. Successful management of fetal hydrops due to congenitally complete atrioventricular block. Sivarajah J, Huggon IC, Rosenthal E. Cardiol Young; 2003 Aug 21; 13(4):380-3. PubMed ID: 14694963 [Abstract] [Full Text] [Related]
9. Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients. Eliasson H, Sonesson SE, Sharland G, Granath F, Simpson JM, Carvalho JS, Jicinska H, Tomek V, Dangel J, Zielinsky P, Respondek-Liberska M, Freund MW, Mellander M, Bartrons J, Gardiner HM, Fetal Working Group of the European Association of Pediatric Cardiology. Circulation; 2011 Nov 01; 124(18):1919-26. PubMed ID: 21986286 [Abstract] [Full Text] [Related]
10. [Complete congenital atrioventricular block. Prenatal diagnosis and perinatal management]. Comas C, Mortera C, Figueras J, Guerola M, Mulet J, Cararach V, Devesa R, Muñoz A, Torrents M, Carrera JM. Rev Esp Cardiol; 1997 Jul 01; 50(7):498-506. PubMed ID: 9304177 [Abstract] [Full Text] [Related]
11. Clinical course of fetal congenital atrioventricular block in the Japanese population: a multicentre experience. Maeno Y, Himeno W, Saito A, Hiraishi S, Hirose O, Ikuma M, Inamura N, Kawataki M, Mizukami A, Ota M, Shiraishi H, Satomi G, Kato H. Heart; 2005 Aug 01; 91(8):1075-9. PubMed ID: 16020601 [Abstract] [Full Text] [Related]
12. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies. Skog A, Wahren-Herlenius M, Sundström B, Bremme K, Sonesson SE. Pediatrics; 2008 Apr 01; 121(4):e803-9. PubMed ID: 18381509 [Abstract] [Full Text] [Related]
13. Effect of maternal betamethasone administration on prenatal congenital cystic adenomatoid malformation growth and fetal survival. Peranteau WH, Wilson RD, Liechty KW, Johnson MP, Bebbington MW, Hedrick HL, Flake AW, Adzick NS. Fetal Diagn Ther; 2007 Apr 01; 22(5):365-71. PubMed ID: 17556826 [Abstract] [Full Text] [Related]
14. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study. Rein AJ, Mevorach D, Perles Z, Gavri S, Nadjari M, Nir A, Elchalal U. Circulation; 2009 Apr 14; 119(14):1867-72. PubMed ID: 19332471 [Abstract] [Full Text] [Related]
15. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies. Chang YL, Hsieh PC, Chang SD, Chao AS, Liang CC, Soong YK. Eur J Obstet Gynecol Reprod Biol; 2005 Oct 01; 122(2):167-71. PubMed ID: 16219517 [Abstract] [Full Text] [Related]
16. Neurological outcome of children who were treated for fetal tachycardia complicated by hydrops. Oudijk MA, Gooskens RH, Stoutenbeek P, De Vries LS, Visser GH, Meijboom EJ. Ultrasound Obstet Gynecol; 2004 Aug 01; 24(2):154-8. PubMed ID: 15287052 [Abstract] [Full Text] [Related]
17. Medical therapy for the hydropic fetus with congenital complete atrioventricular block. Harris JP, Alexson CG, Manning JA, Thompson HO. Am J Perinatol; 1993 May 01; 10(3):217-9. PubMed ID: 8517898 [Abstract] [Full Text] [Related]
18. Maternal steroid therapy for fetuses with immune-mediated complete atrioventricular block: a systematic review and meta-analysis. Ciardulli A, D'Antonio F, Magro-Malosso ER, Saccone G, Manzoli L, Radolec M, Berghella V. J Matern Fetal Neonatal Med; 2019 Jun 01; 32(11):1884-1892. PubMed ID: 29251180 [Abstract] [Full Text] [Related]
19. Twin-to-twin transfusion syndrome with hydrops: a retrospective analysis of ten cases. Hayakawa M, Oshiro M, Mimura S, Katou Y, Takahashi R, Nishikawa H, Ohashi N, Tauchi N, Suzuki C. Am J Perinatol; 1999 Jun 01; 16(6):263-7. PubMed ID: 10586978 [Abstract] [Full Text] [Related]
20. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. van Kamp IL, Klumper FJ, Bakkum RS, Oepkes D, Meerman RH, Scherjon SA, Kanhai HH. Am J Obstet Gynecol; 2001 Sep 01; 185(3):668-73. PubMed ID: 11568796 [Abstract] [Full Text] [Related] Page: [Next] [New Search]